Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?

Anderson, Valerie M; McIlwain, Meghan E; Kydd, Robert R; Russell, Bruce R

Anderson, Valerie M; McIlwain, Meghan E; Kydd, Robert R; Russell, Bruce R.

Affiliation

Anderson VM; School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Centre for Brain Research, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
McIlwain ME; School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Centre for Brain Research, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Kydd RR; Centre for Brain Research, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Department of Psychological Medicine, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Russell BR; School of Pharmacy, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Centre for Brain Research, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Electronic address: b.russell@auckland.ac.nz.

Psychiatry Res ; 230(3): 811-8, 2015 Dec 30.

Article in En | MEDLINE | ID: mdl-26564550

Subject(s)
Key words

Clozapine; Cognition; Memory; Schizophrenia; Treatment-resistant

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Schizophrenic Psychology / Antipsychotic Agents / Drug Resistance / Clozapine / Cognition Disorders Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Psychiatry Res Year: 2015 Document type: Article Affiliation country: Nueva Zelanda Country of publication: Irlanda

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google